SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $614,000 | -51.8% | 179,003 | 0.0% | 0.05% | -50.9% |
| Q1 2022 | $1,275,000 | -49.1% | 179,003 | -40.5% | 0.11% | -42.4% |
| Q4 2021 | $2,505,000 | +16.8% | 300,661 | -2.4% | 0.19% | +24.0% |
| Q3 2021 | $2,144,000 | +644.4% | 308,024 | +1107.9% | 0.15% | +1183.3% |
| Q2 2017 | $288,000 | -24.2% | 25,500 | -24.4% | 0.01% | -40.0% |
| Q1 2017 | $380,000 | -43.5% | 33,732 | -50.3% | 0.02% | -54.5% |
| Q4 2016 | $672,000 | -52.3% | 67,900 | -40.8% | 0.04% | -46.3% |
| Q3 2016 | $1,408,000 | – | 114,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |